The main medication groups most often linked with higher dementia risk over time are:
1. Strong anticholinergic drugs
These block acetylcholine, a key neurotransmitter for memory and attention, so long‑term use can impair thinking and may raise dementia risk. Large case‑control and cohort studies show a dose‑response relationship between cumulative “anticholinergic burden” and later dementia or cognitive impairment, especially in older adults.
Common strong anticholinergics include:
-
Older antihistamines: diphenhydramine (Benadryl), chlorphenamine, doxylamine (often in OTC sleep aids).
-
Bladder antispasmodics: oxybutynin, tolterodine, solifenacin.
-
Tricyclic antidepressants: amitriptyline, imipramine, clomipramine.
-
Some antipsychotics and Parkinson’s “anti‑tremor” drugs (benztropine, trihexyphenidyl).
Geriatric Beers Criteria explicitly flag many of these as “avoid” in older adults because of confusion, falls, and cognitive decline risk.
2. Benzodiazepines and related sedatives
Benzodiazepines (diazepam, lorazepam, clonazepam, etc.) and Z‑drugs (zolpidem, zopiclone) depress the central nervous system and are widely used for anxiety and insomnia. Observational studies link long‑term use to worse cognitive performance and a modestly higher incidence of dementia, though causality is debated because anxiety and sleep problems themselves are risk markers.
Guidelines therefore recommend:
-
Using them short‑term, at the lowest effective dose.
-
Avoiding chronic nightly use in older adults where possible.
-
Tapering slowly under medical supervision rather than stopping abruptly.
3. Polypharmacy with CNS‑active drugs
Research looking at whole prescription patterns finds that taking several central‑nervous‑system drugs together (e.g., combinations of anticholinergics, benzodiazepines, opioids, antipsychotics, anticonvulsants) is associated with higher rates of cognitive decline and dementia than taking one alone.
The more CNS‑depressant and anticholinergic load you carry, the higher your risk of confusion, delirium, falls, and possibly long‑term cognitive harm, particularly after age 65.
